GLP News
Top stories
Prediction markets for GLP
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Nov 18, 10:14 PMJan 1, 4:59 AM
204365
OptionProbability
36
28
21
10
9
0
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
Oct 8, 10:12 PMOct 16, 5:59 AM
14.56%chance
83695
OptionVotes
2422
413
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
Jul 2, 7:40 AMJan 1, 4:59 AM
6.87%chance
213474
OptionVotes
3699
434
By 2030, will LLMs have a bigger impact on the economy than GLP-1 receptor agents?
Oct 3, 12:05 PMJan 2, 4:59 AM
85.19%chance
582894
OptionVotes
974
943
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
Apr 29, 12:40 PMJan 1, 6:59 AM
81.45%chance
332254
OptionVotes
1725
697
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
Feb 7, 1:31 AMJan 1, 7:59 AM
65.43%chance
271378
OptionVotes
1246
789
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
Mar 8, 4:50 PMDec 31, 10:59 PM
30%chance
251266
OptionVotes
1194
845
Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms
Jun 26, 2:19 AMDec 31, 11:59 PM
67.73%chance
3537
OptionVotes
1449
690
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
Jan 20, 9:19 AMDec 31, 10:59 PM
85.51%chance
3204
OptionVotes
1096
949
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
Aug 20, 2:29 AMFeb 1, 4:59 AM
41.86%chance
8173
OptionVotes
268
85
Will a majority government owned company introduce a new GLP-1 drug before 2040?
Jan 25, 9:23 PMDec 31, 10:59 PM
15.33%chance
1135
OptionVotes
235
43
Joel Habener wins the Nobel Prize in Physiology or Medicine before 2030 for isolating and characterizing GLP-1
Apr 11, 10:52 AMDec 31, 11:59 PM
51.13%chance
7104
OptionVotes
102
98
Latest stories
Latest stories